They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...
Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...
Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for ...
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...
Losing weight can be a challenge for many. With so many variables present in everyday life, including stress, lack of sleep, ...
People around the UK who are taking weight-loss drugs that suppress the appetite, such as Mounjaro, fear they won't be able to enjoy a 'normal' Christmas because they simply can't eat or drink ...
The Mounjaro jab has been branded the “King Kong of weight-loss drugs” and could offer life-changing support for people in the UK struggling with obesity. It’s been advised that people with ...
A new drug dubbed the “King Kong” of weight-loss jabs will be available in Ireland early next year, it was confirmed yesterday. Mounjaro, a brand name for tirzepatide, can be used to treat ...
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.
Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period.
Mounjaro and Zepbound. Those drugs brought in a combined $4.4 billion in sales for Lilly in this year’s third quarter. The drugmaker plans to start construction of the expansion next year.